Condition

Breast Neoplasm Malignant Female

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 13 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials13
Recruiting2
Common interventions17
Lead sponsors shown13
Advertisement

Clinical trials

13 shown
Step Count and Treatment Response in Neoadjuvant Breast CancerNCT07162675 · 2025-09-08
RECRUITING
Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast CancerNCT06938724 · 2025-07-25
RECRUITING
Supervised Exercise During Neoadjuvant Chemotherapy for Breast CancerNCT07764341 · 2026-09-01
NOT_YET_RECRUITING
Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by LumpectomyNCT05941299 · 2023-09-29
ACTIVE_NOT_RECRUITING
Study of the Impact of DPD Activity on the Efficacy of CapecitabineNCT04198727 · 2020-07-20
ACTIVE_NOT_RECRUITING
Use of Microporous Polysaccharide Hemispheres in Breast Cancer Patients Undergoing MastectomyNCT06824831 · 2020-06-01
COMPLETED
SBRT for Breast Cancer OligometastasesNCT04424732 · 2020-06-01
UNKNOWN
Interest of Touch-massage in Hospital Day CareNCT04348955 · 2019-10-07
COMPLETED
PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast CancerNCT05812326 · 2019-05-17
COMPLETED
Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)NCT04289805 · 2019-02-25
TERMINATED
Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer PatientsNCT03525990 · 2018-01-10
COMPLETED
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)NCT03109080 · 2017-07-24
COMPLETED
Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009NCT05134922
AVAILABLE

Common interventions

Trial status mix

COMPLETED5
ACTIVE_NOT_RECRUITING2
RECRUITING2
AVAILABLE1
NOT_YET_RECRUITING1
TERMINATED1
UNKNOWN1

Phase mix

NA4
PHASE23
PHASE12
PHASE42
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.